metricas
covid
Buscar en
Vacunas (English Edition)
Toda la web
Inicio Vacunas (English Edition) Knowledge, attitudes, and adherence of the Cape Verdean population to the COVID-...
Journal Information
Vol. 25. Issue 2.
Pages 203-213 (April - June 2024)
Share
Share
Download PDF
More article options
Visits
40
Vol. 25. Issue 2.
Pages 203-213 (April - June 2024)
Original
Knowledge, attitudes, and adherence of the Cape Verdean population to the COVID-19 vaccine
Visits
40
Maria de Fátima Carvalho Alves
Corresponding author
Mariafatima.Alves@insp.gov.cv

Corresponding author at: Instituto Nacional de Saúde Pública, Largo do Desastre da Assistência, Chã de Areia, C.P. 719 Cidade da Praia, Cape Verde.
, Janice de Jesus Soares, Maria da Luz Lima Mendonça
National Institute of Public Health (INSP), Department of Research, Science and Training, Praia, Cape Verde
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (5)
Table 1. Sociodemographic data.
Table 2. Vaccine knowledge.
Table 3. Attitudes towards vaccination.
Table 4. Population for or against vaccination.
Table 5. Binary logistic regression to measure the effect of sociodemographic variables on vaccine safety, intention to vaccinate, and recommendation of the COVID-19 vaccine in the Cape Verdean population, 2020.
Show moreShow less
Abstract
Background

The spread of the COVID-19 pandemic at the end of 2019, with its well-known consequences in terms of morbidity and mortality, has triggered an intense mobilization of the scientific community in the search for knowledge about the SARS-Cov2 virus and the development of a vaccine.

Objective

This study aims to investigate the knowledge, perceptions, attitudes, and intentions of the resident Cape Verdean population regarding the COVID-19 vaccine.

Methods

This was a descriptive, cross-sectional, and analytical study involving 1704 resident Cape Verdeans, whose ages ranged from 16 to 60 years old and the majority of participants were male (52.6%). The data was collected using the Google form platform between March 9 and 15, 2021.

Results

The data indicated that the majority of participants (95.8%) knew of at least one approved vaccine against COVID-19, and this knowledge (74.9%) was obtained from television, radio, and newspapers. The Oxford-AstraZeneca vaccine was the best known (54.1%) among the study subjects and the majority of respondents (69.7%) had enough information to consciously decide whether or not to get vaccinated against COVID-19. The majority (68.0%) of participants were in favor of the COVID-19 vaccine being administered to all interested people. About 59% of participants considered the COVID-19 vaccine to be safe and 49.6% of participants intended to get vaccinated when the time came. The greatest vaccine hesitancy was related to fear of side effects (21.4%), followed by the fact that it was developed too quickly (12.8%). Health professionals were seen as the priority group (81.5%) to be vaccinated.

Conclusions

The results show that the Cape Verdean population had a good level of knowledge about the COVID-19 vaccine. Despite initial hesitation, the vast majority of participants were willing to get vaccinated. These data suggest that awareness-raising, education, and information campaigns about the COVID-19 vaccine should be strengthened to reduce hesitation and increase confidence and adherence to the COVID-19 vaccine among Cape Verdean residents.

Keywords:
COVID-19 vaccine
Attitudes and hesitancy to the COVID-19 vaccine
COVID-19 in Cape Verde
Resumen
Antecedentes

La propagación de la pandemia de COVID-19 a finales de 2019, con sus conocidas consecuencias en términos de morbilidad y mortalidad, ha desencadenado una intensa movilización de la comunidad científica en la búsqueda de conocimientos sobre el virus SARS-Cov2 y el desarrollo de una vacuna.

Objetivo

Este estudio pretende investigar los conocimientos, percepciones, actitudes e intenciones de la población caboverdiana residente en relación a la vacuna COVID-19.

Método

Se trata de un estudio descriptivo, transversal y analítico en el que participaron 1.704 caboverdianos residentes, cuyas edades oscilaban entre los 16 y los 60 años y la mayoría de los participantes eran hombres (52,6%). Los datos se recogieron utilizando la plataforma de formularios de Google entre el 9 y el 15 de marzo de 2021.

Resultados

Los datos indicaron que la mayoría de los participantes (95,8%) conocían al menos una vacuna aprobada contra el COVID-19, y este conocimiento (74,9%) lo obtuvieron de la televisión, la radio y los periódicos. La vacuna de Oxford-AstraZeneca era la más conocida (54,1%) entre los sujetos del estudio y la mayoría de los encuestados (69,7%) disponía de información suficiente para decidir conscientemente si vacunarse o no contra el COVID-19. La mayoría (68,0%) de los participantes estaba a favor de que la vacuna COVID-19 se administrara a todas las personas interesadas. Alrededor del 59% de los participantes consideraban que la vacuna COVID-19 era segura y el 49,6% de los participantes tenían intención de vacunarse llegado el momento. Las mayores dudas sobre la vacuna estaban relacionadas con el miedo a los efectos secundarios (21,4%), seguido del hecho de que se desarrollara demasiado rápido (12,8%). Los profesionales sanitarios se consideraron el grupo prioritario (81,5%) para vacunarse.

Conclusiones

Los resultados muestran que la población caboverdiana tenía un buen nivel de conocimiento sobre la vacuna COVID-19. A pesar de las dudas iniciales, la gran mayoría de los participantes estaban dispuestos a vacunarse. Estos datos sugieren que deberían reforzarse las campañas de concienciación, educación e información sobre la vacuna COVID-19 para reducir las dudas y aumentar la confianza y la adherencia a la vacuna COVID-19 entre los residentes de Cabo Verde.

Palabras clave:
Vacuna COVID-19
Actitudes y dudas ante la vacuna COVID-19
COVID-19 en Cabo Verde

Article

These are the options to access the full texts of the publication Vacunas (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Vacunas (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos